News

Fitch Upgrades Bausch + Lomb, Bausch Health But Keeps Both Junk
Fitch Ratings upgraded its credit grade on both Bausch + Lomb Corp. and its parent company Bausch Health Cos., but said the ...
Bausch + Lomb recalls lenses used in cataract surgery due to inflammatory reactions
Bausch + Lomb issued the recall after the company received reports of toxic anterior segment syndrome, or an inflammatory ...
Bausch Health Announces Adoption of Shareholder Rights Plan
LAVAL, QC / ACCESS Newswire / April 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch ...
Bausch says court grants summary judgment in favor of FDA, Salix, and Teva
Bausch Health Companies (BHC) and its gastroenterology business, Salix Pharmaceuticals, announced the U.S. District Court for the District of ...
Bausch Health: Repositioning Aplezin As First Oral Monotherapy For TRD A $3 Billion Opportunity
Bausch Health's Aplenzin could revolutionize TRD care, addressing a $3B market opportunity while aiding BHC stock's financial ...
Bausch + Lomb recalls several intraocular contact lens systems
Bausch + Lomb, a leading global eye health company, announced a voluntary recall of its Envista Aspire, Envista Envy and ...
Bausch + Lomb announces lenses recall: Here’s what to know
The eye health company Bausch + Lomb announced on Monday that it is recalling several of its intraocular lenses due to safety ...
Bausch + Lomb (BLCO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / April 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
ConsumerAffairs10d
Bausch + Lomb recalls some enVista intraocular lenses
Bausch + Lomb is recalling intraocular lenses (IOLs) on its enVista platform. This action was taken after the company ...
Hosted on MSN11d
Q4 Earnings Roundup: Bausch + Lomb (NYSE:BLCO) And The Rest Of The Medical Devices & Supplies - Specialty Segment
Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst ...
MPR7d
Bausch + Lomb Issues Recall of enVista Lenses Used in Cataract Surgery
HealthDay News — Bausch + Lomb has announced a voluntary recall of intraocular lenses on its enVista platform due to the potential for an acute postoperative inflammatory reaction.
Investing.com Australia1d
Bausch Health shares jump on favorable court ruling
Investing.com -- Bausch Health Companies Inc (NYSE: BHC) stock closed up 13.3% following a favorable court decision. The U.S. District Court for the District of Columbia ruled in favor of the company ...